1. Omalizumab as a last resort therapy for intractable, severe chronic allergic rhinosinusitis

   • Ciro Romano
   • Gianvito Pace
   • Alfonso Reginelli

   case report 24 October 2018 Pages: 99 - 102

   

2. Case series of anaphylactic reactions after rabies vaccinations with gelatin sensitization

   • Fabienne Bradfisch
   • Michael Pietsch
   • Joachim Saloga

   original article 18 April 2019 Pages: 103 - 106

   

3. Development of subcutaneous allergen immunotherapy (part 2): preventive aspects and innovations

   • Ludger Klimek
   • Randolf Brehler
   • Oliver Pfaar

   review Open access 13 May 2019 Pages: 107 - 119